IP Library Granted Patent US 10,759,834
Granted Patent B2
US 10,759,834 · App. 15/519,576 · Granted Sep 1, 2020

Methods and compositions involving protein G variants

Inventors: Anthony A. Kossiakoff (Chicago, IL); Lucas J. Bailey (Chicago, IL)
Assignee: The University of Chicago
C07K14/315C07K1/22C07K16/00C07K17/00G01N33/54353C07K2317/55C07K2319/00C07K2319/01C07K2319/70G01N2333/315
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,759,834
App. No.
15/519,576
Granted
Sep 1, 2020
Kind
B2
Abstract

Methods and compositions are provided concerning polypeptides with modifications that increase its binding affinity for the Fab region of an antibody. Methods include using the polypeptides for isolating, detecting, purifying, measuring and quantifying Fab polypeptides. Other embodiments concern kits, compositions, and solid supports containing the polypeptides and for using the polypeptides for isolating, detecting, purifying, measuring and quantifying Fab polypeptide.

Claims (12)

1. A polypeptide comprising a modified protein G Fab-binding domain wherein the modified protein G fab binding domain comprises an amino acid sequence having at least 80% sequence identity with SEQ ID NO:3.

2. The polypeptide of claim 1 , wherein the polypeptide further comprises a variant immunogenicity region, wherein the variant immunogenicity region comprises a an amino acid sequence having at least 80% sequence identity with one of SEQ ID NOS:27-49.

3. The polypeptide of claim 2 , wherein the variant immunogenicity region has an amino acid sequence selected from SEQ ID NOS:27-49.

4. The polypeptide of claim 1 , wherein the polypeptide further comprises one or more F c regions and/or a targeting moiety.

5. A fusion protein comprising two or more polypeptides of claim 1 .

6. A protein complex comprising the polypeptide of claim 1 operatively linked to at least one Fab polypeptide.

7. The polypeptide of claim 1 , wherein the modified protein G fab binding domain comprises an amino acid sequence having at least 83% sequence identity with SEQ ID NO:3.

8. The polypeptide of claim 1 , wherein the modified protein G fab binding domain comprises an amino acid sequence having at least 90% sequence identity with SEQ ID NO:3.

9. The polypeptide of claim 1 , wherein the protein G Fab-binding domain comprises a variant isotype recognition region at amino positions corresponding to positions 24-29 of SEQ ID NO:3 and wherein the variant isotype recognition region consists of SEQ ID NO:20.

10. The polypeptide of claim 8 , wherein the protein G Fab-binding domain comprises a variant isotype recognition region at amino positions corresponding to positions 24-29 of SEQ ID NO:3 and wherein the variant isotype recognition region consists of SEQ ID NO:20.

11. A nucleic acid encoding for a polypeptide comprising a modified protein G Fab-binding domain wherein the modified protein G fab binding domain comprises an amino acid sequence having at least 80% sequence identity with SEQ ID NO:3.

12. A method for making a polypeptide comprising expressing a nucleic acid encoding for a polypeptide comprising a modified protein G Fab-binding domain wherein the modified protein G fab binding domain comprises an amino acid sequence having at least 80% sequence identity with SEQ ID NO:3 in a host cell.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 25, 2018
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046419/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2017
From: KOSSIAKOFF, ANTHONY; BAILEY, LUCAS
To: THE UNIVERSITY OF CHICAGO
Reel/Frame 042025/0760 →
Continuity (3)
Provisional Application 62065156 · Oct 17, 2014
Provisional Application 62065516 · Oct 17, 2014
Related Publication 20180044385A1 · Feb 15, 2018